ClinicalTrials.Veeva

Menu

Measurement of the Prevalence of Sensory Integration Disorders in Babies Having Heart Disease Surgery for Transposition of the Great Vessels Before 6 Months of Age (SENSOCOEUR)

A

Assistance Publique - Hôpitaux de Paris

Status

Enrolling

Conditions

Great Vessels Transposition Surgery

Treatments

Other: Dunn-2 infant Sensory Profile (PS2-N)

Study type

Observational

Funder types

Other

Identifiers

NCT05137873
2021-A02294-37 (Other Identifier)
APHP211266

Details and patient eligibility

About

The purpose of this study is to mesure the prevalence of severe sensory integration disorders in babies after one week of their heart surgery.

Full description

Baby's development takes its roots in sensorimotricity. Baby coordinates different senses (visual, auditory, tactile, taste, vestibular) to understand the space around him and to implement voluntary motor strategies. These sensory links also allow him to invest hisoral zone and consolidate his oral feeding. Another good sensory integration is necessary for a child to develop harmoniously on motor and psychic levels. In 2018 the study of L. Dagenais revealed a gap in posturomotor development on babies operated on for isolated congenital heart disease. However nobody assess sensory disorders in these babies. With this study the investigators wish to clarify the sensory impact in this situation.

Enrollment

60 estimated patients

Sex

All

Ages

Under 6 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infant born at term (over 37 weeks)
  • With heart disease, of the transposition of the great vessels type, whether or not associated with an interventricular communication
  • Having a cranial perimeter in the norm at birth: between 32 and 37 cm.
  • Surgery scheduled before the age of 6 months
  • No opposition from parents

Exclusion criteria

  • Other disease or malformation
  • Parents who do not speak French

Trial design

60 participants in 1 patient group

Surgery before 6 months of age
Description:
Babies with heart disease surgery, great vessels transposition surgery type before 6 months of age
Treatment:
Other: Dunn-2 infant Sensory Profile (PS2-N)

Trial contacts and locations

1

Loading...

Central trial contact

Laure Choupeaux, Msc; Gaelle Malecot le Meur, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems